Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " February 02, 2007":" March 02, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" February 02, 2007":" March 02, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor
Condition: HIV Infections
Intervention:
2 Completed Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes
Condition: HIV Infections
Intervention:
3 Completed Effects of Anti-HIV Therapy on Nervous System Function
Condition: HIV Infections
Intervention:
4 Completed Pharmacogenetics of Antiretroviral Drugs
Condition: HIV Infections
Intervention:
5 Active, not recruiting Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand
Condition: HIV Infections
Intervention:
6 Completed Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients
Condition: HIV Infection
Intervention:
7 Completed Lopinavir Capsules to Kaletra or Invirase Tablets
Condition: HIV Infections
Interventions: Drug: Saquinavir (Invirase®);   Drug: Lopinavir/ritonavir (Kaletra®)
8 Completed Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide
Condition: HIV Infections
Interventions: Drug: UC-781;   Drug: UC-781 placebo
9 Completed Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV
Condition: HIV Infections
Interventions: Drug: zidovudine;   Drug: amdoxovir;   Procedure: pharmacokinetic sampling
10 Completed Study of Pharmacokinetics in HIV-infected Women
Condition: HIV Infections
Intervention: Drug: antiretroviral treatment
11 Terminated
Has Results
MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)
Condition: HIV Infection
Interventions: Drug: Comparator: raltegravir;   Drug: Comparator: placebo;   Drug: Comparator: lopinavir (+) ritonavir
12 Terminated
Has Results
MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)
Condition: HIV Infection
Interventions: Drug: MK0518 (raltegravir);   Drug: Comparator: KALETRA™ (lopinavir (+) ritonavir );   Drug: Comparator: placebo
13 Completed
Has Results
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
Condition: HIV Infections
Interventions: Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate
14 Terminated
Has Results
SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir;   Drug: Optimized Background Regimen (OBR)
15 Completed Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications
Condition: HIV Infections
Intervention:
16 Completed Long Term Treatment Interruptions
Conditions: HIV Infections;   AIDS
Interventions: Other: STI;   Drug: stable HAART
17 Completed
Has Results
Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: EVG;   Drug: RTV;   Drug: ARV regimen
18 Completed Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Placebo (Universal HEC placebo)
19 Completed A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701
Condition: HIV Infection
Intervention: Drug: No Intervention -- Observational study
20 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.